Emergen Research

The global Chronic Rhinosinusitis Market was valued at USD 2132.5 million in 2019 and is expected to reach USD 3508.0 million by 2027

SURREY, BRITISH COLUMBIA, CANADA , April 13, 2022 /EINPresswire.com/ -- The latest and updated research report on the Global Chronic Rhinosinusitis Market covers a comprehensive overview of the Chronic Rhinosinusitis market, future economic condition, competitive landscape mapping, supply and demand trends, and production and consumption analysis. The report also covers the influence of the COVID-19 pandemic on the Chronic Rhinosinusitis market. The pandemic has dynamically affected all aspects of life on a global scale along with drastic changes in the economy and market conditions. The report covers the currently fluctuating market scenario along with present and future assessment of the COVID-19 impact. The report encompasses the historical data, company overview, financial standing, and necessary information about the new and key players of the market.

Adoption of minimally invasive techniques, technological advancements, substantial prevalence of rhinosinusitis with favorable reimbursement scenarios are forecasted to fuel the market growth.

Chronic Rhinosinusitis Market Size – USD 2132.5 Million in 2019, Market Growth – CAGR of 7.4%, Market Trends– growing prevalence of chronic asthma, potential investment opportunities and technological advancements is expected to fuel the market in the forecast period

Get a sample of the report : https://www.emergenresearch.com/request-sample/74

Roughly more than 15 million people suffer from chronic symptoms of rhinosinusitis in the United States, that is, prevalence of chronic rhinosinusitis ranges from 1% to 5% of the total US population. Chronic rhinosinusitis is primarily characterized by nasel blockage, inflammation of the sinus and nasel linings, facial pain along with rhinorrhea and loss of sense of smell. Effective treatment includes improvement in sinus outflow, enhancement of mucociliary clearance and elimination of inflammation and local infection among other associated treatments.

Key market companies studied and profiled for this research include AstraZeneca, Bayer AG, Ivax Pharmaceuticals, Pfizer, Novartis Pharmaceuticals Corporation, Sanofi, Sunovion Pharmaceuticals, Cipla, Smith Nephew, Medtronic, SinuSys Corporation, Olympus Corporation and Acclarent among other companies

Effective treatment includes improvement in sinus outflow, enhancement of mucociliary clearance and elimination of inflammation and local infection among other associated treatments.Additionally, increase in implementation of minimally invasive surgical procedures, widespread awareness concerning the symptoms of the target disease across regions and technological progressions among other favorable scenarios are likely to augment the growth of industry during the period of 2020-2027. However, low preference towards sinus surgical undertakings, post-surgery risks of sinus treatment and high cost of treatment may hinder the growth of chronic rhinosinusitis market in the forecast period.

Regeneron Pharmaceuticals and Sanofi’s Dupixent (Dupilumab) was approved in June 2019, by US Food and Drug Administration (FDA). This drug is customized for adults with incompetently controlled chronic rhinosinusitis along with nasal polyposis

Owing to favourable reimbursement policies, high prevalence of target disease and technological advancements among other encouraging scenarios North America accounted for largest market revenue with significant market share of 37.2% in 2019

Xolair (Omalizumab) manufactured by Novartis, was approved in August 2020, by European Commission (EC). The product development is attributed to treat severe chronic rhinosinusitis with nasal polypsDue to considerable employability of antibiotics and their effectiveness in efficiently treating chronic rhinosinusitis, antibiotics product segment held largest market share of 41.6% in 2019 and is likely to dominate the industry during 2019-2027

Immune deficiency disease segment in the disease outlook registered highest CAGR of 7.1% in 2019 whereas, anatomical differences disease segment accounted for largest market share of approximately 37.5% owing to increase in prevalence of target disease across the globe

To know more about the report: https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

Highlights of the TOC:

1. Report Overview
1.1 Research Scope
1.2 Key Chronic Rhinosinusitis market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline

2. Global Growth Trends
2.1 Global Chronic Rhinosinusitis market size
2.2 Latest Chronic Rhinosinusitis market trends
2.3 Key growth trends

3. Competitive Landscape
3.1 Global Chronic Rhinosinusitis market key players
3.2 Global Chronic Rhinosinusitis size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Chronic Rhinosinusitis market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances

Emergen Research have segmented Chronic Rhinosinusitis Market on the basis of product, disease type, distribution channel and region:

Product Outlook (Revenue in Million USD; 2017–2027)

Steroids

Topical Nasal Steroid

Systemic Steroids

Nasal Irrigation

Hypertonic and Isotonic Saline

Steroid Nasal Irrigation

Topical Antibiotic Therapy

Surgical Based

Ethmoidectomy

Endoscopic Intranasal Intervention

Others

Antibiotics

Amoxicillin-Clavulanate

Clindamycin

Sulfamethoxazole

Levofloxacin

Macrolide Therapy

Antifungal Therapy

Disease Outlook (Revenue in Million USD; 2017–2027)

Anatomical Differences

Nasal Tumors

Mucosal Edema

Non-Allergic Rhinitis

Immune Deficiency

Other

Distribution Channel (Revenue in Million USD; 2017–2027)

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Other

Key Points of Chronic Rhinosinusitis Market:

Extensive coverage of the analysis of the Chronic Rhinosinusitis market

Key insights into the regional spread of the industry in key geographies

Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market

Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Chronic Rhinosinusitis market

Complete data about the key manufacturers and vendors in the Chronic Rhinosinusitis market

Request a discount on the report : https://www.emergenresearch.com/request-discount/74

Related reports:

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Medical Radiation Detection, Monitoring, and Safety Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.